Association of the DeRitis ratio with insulin resistance in non-obese adults ‒ a cross-sectional study from South India
DOI:
https://doi.org/10.15584/ejcem.2026.1.21Keywords:
alanine transaminase, aspartate aminotransferase, body weight, insulin resistance, IndiaAbstract
Introduction and aim. Beyond overt obesity, insulin resistance (IR) is increasingly recognized in non-obese individuals, particularly South Asians. Liver enzymes, especially aspartate aminotransferase (AST) and alanine aminotransferase (ALT), and their ratio (DeRitis) have emerged as potential surrogate markers of metabolic dysfunction. To the best of our knowledge, this is the first study to evaluate the DeRitis ratio as a surrogate marker of IR specifically in non-obese South Indian adults, addressing an important evidence gap. With this background, the aim was to estimate the IR prevalence in non-obese adults by homeostasis model assessment of IR (HOMA-IR) and to assess the correlation and diagnostic performance of the DeRitis ratio.
Material and methods. This cross-sectional study included 100 non-obese adults (body mass index (BMI) <25kg/m²) selected using a convenience sampling technique attending a tertiary care hospital in Pondicherry, India. Data collected by structured proforma and biochemical assays of fasting plasma glucose, fasting insulin, and liver enzymes. HOMA-IR ≥2.5 as confirmed IR. The correlation and diagnostic accuracy of the DeRitis ratio for predicting IR was analyzed using SPSS software (V_25.0); p<0.05 considered statistically significant.
Results. IR (HOMA-IR 2.5) was present in 13% of participants. Overweight individuals showed significantly higher fasting insulin levels and HOMA-IR values compared to adults with normal BMI. The DeRitis ratio was positively correlated with HOMA-IR (r=0.516, p<0.001). Using the cut-off AST/ALT >1.0, the ratio demonstrated good discriminatory ability for IR (AUC=0.778), with 82.5% sensitivity and 83.3% specificity.
Conclusion. The DeRitis ratio shows moderate discrimination for IR and may aid in screening where insulin assays are limited. Validation in larger, multicenter cohorts is warranted.
Downloads
References
NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults. Lancet. 2024;403(10431):1027-1050. doi:10.1016/S0140-6736(23)02750-2
James WPT. WHO recognition of the global obesity epidemic. Int J Obes. 2008;32(suppl 7):S120-S126. doi:10.1038/ijo.2008.247
El-Eshmawy MM. Impact of obesity on liver function tests: Is nonalcoholic fatty liver disease the only player? A review article. Porto Biomed J. 2023;8(5):e228. doi:10.1097/j.pbj.0000000000000228
Jalili V, Poorahmadi Z, Hasanpour Ardekanizadeh N, et al. The association between obesity with serum levels of liver enzymes, alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase and gamma‐glutamyl transferase in adult women. Endocrinol Diabetes Metab. 2022;5(6):e367. doi:10.1002/edm2.367
World Health Organization. One in eight people are now living with obesity. WHO News. https://www.who.int/news/item/01-03-2024-one-in-eight-people-are-now-living-with-obesity. Accessed September 3, 2025.
Ghotbi S, Joukar F, Orang Goorabzarmakhi M, et al. Evaluation of elevated serum liver enzymes and metabolic syndrome in the PERSIAN Guilan cohort study population. Heliyon. 2024;10(11):e32449. doi:10.1016/j.heliyon.2024.e32449
Arneth B. Mechanisms of Insulin Resistance in Patients with Obesity. Endocrines. 2024;5(2):153-165. doi:10.3390/endocrines5020011
Zhao X, An X, Yang C, Sun W, Ji H, Lian F. The crucial role and mechanism of insulin resistance in metabolic disease. Front Endocrinol. 2023;14:1149239. doi:10.3389/fendo.2023.1149239
Jin X, Qiu T, Li L, et al. Pathophysiology of obesity and its associated diseases. Acta Pharm Sin B. 2023;13(6):2403-2424. doi:10.1016/j.apsb.2023.01.012
Geißler C, Krause C, Neumann AM, et al. Dietary induction of obesity and insulin resistance is associated with changes in Fgf21 DNA methylation in liver of mice. J Nutr Biochem. 2022;100:108907. doi:10.1016/j.jnutbio.2021.108907
Shaikh SM, Varma A, Kumar S, Acharya S, Patil R. Navigating disease management: a comprehensive review of the De Ritis ratio in clinical medicine. Cureus. 2024;16(7):e64447. doi:10.7759/cureus.64447
Ndrepepa G, Holdenrieder S, Kastrati A. Prognostic value of DeRitis ratio with aspartate aminotransferase and alanine aminotransferase within the reference range. Clin Chim Acta. 2023;538:46-52. doi:10.1016/j.cca.2022.11.005
Li Q, Lan W. Association between DeRitis ratio (AST/ALT) and mortality in patients with chronic kidney disease: a retrospective cohort study. Sci Rep. 2025;15:9649. doi:10.1038/s41598-025-93184-1
Kawamoto R, Kohara K, Kusunoki T, Tabara Y, Abe M, Miki T. Alanine aminotransferase/aspartate aminotransferase ratio is the best surrogate marker for insulin resistance in non-obese Japanese adults. Cardiovasc Diabetol. 2012;11(1):117. doi:10.1186/1475-2840-11-117
Han SK, Seo MJ, Lee T, Kim MY. Effectiveness of the ALT/AST ratio for predicting insulin resistance in a Korean population: A large-scale, cross-sectional cohort study. PLOS ONE. 2024;19(5):e0303333. doi:10.1371/journal.pone.0303333
Vozarova B, Stefan N, Lindsay RS, et al. High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes. Diabetes. 2002;51(6):1889-1895. doi:10.2337/diabetes.51.6.1889
Narayan KMV, Kanaya AM. Why are South Asians prone to type 2 diabetes? A hypothesis based on underexplored pathways. Diabetologia. 2020;63(6):1103-1109. doi:10.1007/s00125-020-05132-5
Misra A, Soares MJ, Mohan V, et al. Body fat, metabolic syndrome and hyperglycemia in South Asians. J Diabetes Complications. 2018;32(11):1068-1075. doi:10.1016/j.jdiacomp.2018.08.001
Venkatrao M, Nagarathna R, Majumdar V, Patil SS, Rathi S, Nagendra H. Prevalence of obesity in India and its neurological implications: a multifactor analysis of a nationwide cross‑sectional study. Ann Neurosci. 2020;27(3-4):153-161. doi:10.1177/0972753120987465
Mahajan K, Batra A. Obesity in adult asian indians- the ideal BMI cut-off. Indian Heart J. 2018;70(1):195. doi:10.1016/j.ihj.2017.11.020
Minh HV, Tien HA, Sinh CT, et al. Assessment of preferred methods to measure insulin resistance in Asian patients with hypertension. J Clin Hypertens. 2021;23(3):529-537. doi:10.1111/jch.14155
Ahirwar R, Mondal PR. Prevalence of obesity in India: A systematic review. Diabetes Metab Syndr Clin Res Rev. 2019;13(1):318-321. doi:10.1016/j.dsx.2018.08.032
Misra A, Khurana L. Obesity and the metabolic syndrome in developing countries. J Clin Endocrinol Metab. 2008;93(11 Suppl 1):S9-30. doi:10.1210/jc.2008-1595
Chan K, De Souza LR, Kobayashi K, Fuller-Thomson E. Diabetes and diabetes care among non-obese South Asian Americans: Findings from a population-based study. Diabetes Metab Syndr. 2019;13(1):96-102. doi:10.1016/j.dsx.2018.08.025
Momo FR, Hoque MR, Sarkar S, Faysal MR, Mitu SA, Suchi SS. Comparison of serum alanine aminotransferase and aspartate aminotransferase among obese and non‑obese adults. Mymensingh Med J MMJ. 2024;33(4):955-961.
Song HR, Yun KE, Park HS. Relation between alanine aminotransferase concentrations and visceral fat accumulation among nondiabetic overweight Korean women. Am J Clin Nutr. 2008;88(1):16-21. doi:10.1093/ajcn/88.1.16
DeRitis F, Coltorti M, Giusti G. An enzymic test for the diagnosis of viral hepatitis: The transaminase serum activities. Clin Chim Acta. 2006;369(2):148-152. doi:10.1016/j.cca.2006.05.001
Botros M, Sikaris KA. The De Ritis ratio: the test of time. Clin Biochem Rev. 2013;34(3):117-130.
Lee S, Lacy ME, Jankowich M, Correa A, Wu WC. Association between obesity phenotypes of insulin resistance and risk of type 2 diabetes in African Americans: The Jackson Heart Study. J Clin Transl Endocrinol. 2020;19:100210. doi:10.1016/j.jcte.2019.100210
Raj A, Vijayakumar V. Correlation of HOMA IR with BMI. Asian J Med Res. 2021;10(3):5-8.
Mirzaalian Y, Nourian M, Gholamalizadeh M, et al. The association of quantitative insulin sensitivity indices (HOMA-IR and QUICKI) with anthropometric and cardiometabolic indicators in adolescents. Arch Med Sci Atheroscler Dis. 2019;4:e32-e37. doi:10.5114/amsad.2019.84411
Park MS. Triglyceride-glucose index predicts future metabolic syndrome in an adult population, Korea: a prospective cohort study. Ann Clin Nutr Metab. 2024;16(3):168-172. doi:10.15747/ACNM.2024.16.3.168
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 European Journal of Clinical and Experimental Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition: this means that articles have free availability on the public Internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from having access to the Internet itself.
All articles are published with free open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0). If you submit your paper for publication by the Eur J Clin Exp Med, you agree to have the CC-BY license applied to your work. Under this Open Access license, you, as the author, agree that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. This facilitates freedom in re-use and also ensures that Eur J Clin Exp Med content can be mined without barriers for the research needs.
